Skip to content
Wenlo
Sign in
← Markets

Candel Therapeutics, Inc.

Maria Ostrovsky (General Counsel) reports CADL insider transactions

4CADLFiled Nov 5, 2026, 11:24 AM ET· Period Nov 3, 2026

About this filing

Candel Therapeutics, Inc. (CADL) filed Form 4 (insider transaction) with the SEC on Nov 5, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Maria Ostrovsky · General Counsel
DateTransactionSharesPriceValueHeld afterOwnership
Nov 3, 2026A · grantStock Option (Right to Buy)Footnotes F1+315,000$0.00$0.00315,000Direct
Footnotes
  1. F1 25% of the shares underlying this option shall vest and become exercisable on November 3, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

More CADL filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.